Annovis Bio Inc
Biotechnology
Healthcare
ANVS
12.98 M shares
NYSE MKT US
traded
03 Apr 2025
listed
no
open
1.54
52 week high
15.46
high
1.54
52 week low
1.41
low
1.40
growth
-80.66 %
previous Close
1.59
P/E ratio
market cap
61.54 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-12.64 B
-251.00 %
eps
0.00 %
-203.13 %
eps surprise
-83.02 %
net profit margin
-1263835700000.00 %
0.00 %
operating incoming
-4.39 M
43.48 %
net change in cash
8.64 M
903.59 %
cash on hand
12.64 M
216.09 %
cost of revenue
0.00 %
top top